PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEFSeptember 14, 2021DiabetesObesityCardiologyEndocrinology
At 18 months, much still unknown about diabetes and COVID-19September 13, 2021COVID-19 UpdatesDiabetesEndocrinology
‘Quadpill’ bests monotherapy for initial BP lowering: QUARTETSeptember 13, 2021CardiologyEndocrinology
When should patients with kidney disease receive nephrology referral?September 3, 2021NephrologyEndocrinology
EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEFAugust 31, 2021DiabetesCardiologyEndocrinology
Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HFAugust 27, 2021DiabetesCardiologyEndocrinology
EMPEROR-Preserved: Empagliflozin scores HFpEF breakthroughAugust 27, 2021DiabetesCardiologyEndocrinology
‘Countdown to zero’: Endocrine disruptors and worldwide sperm countsAugust 26, 2021Mixed TopicsWomen's HealthMen's HealthEndocrinology
US Preventive Services Task Force lowers diabetes screening age for overweightAugust 24, 2021DiabetesObesityCardiologyEndocrinology
SGLT2 inhibitor use rising in patients with DKDAugust 23, 2021DiabetesCardiologyNephrologyEndocrinology
Pandemic derails small success in lowering diabetes-related amputationsAugust 19, 2021DiabetesEndocrinologyNeurologyDiversity in MedicinePain
